AIM This pilot study aimed to evaluate the individual features of the metabolic syndrome (MeS) and its frequency in Qatari schoolchildren aged 6-12 years. BACKGROUND MeS has a strong future risk for development of diabetes and cardiovascular diseases. Childhood obesity is increasing the likelihood of MeS in children. METHODS The associated features of MeS were assessed in 67 children. They ...

Metabolic syndrome (MS) is a rising disease entity characterized by a clustering of metabolic conditions. Although prevalence of obesity as defined by the World Health Organization (WHO) is relatively low in Asia compared to western countries, metabolic syndrome is growing into a significant public health problem. Comparative studies indicate that metabolic responses to obesity may be greater i...

According to current guidelines from the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III), the target low-density lipoprotein cholesterol (LDL-C) level for patients with established coronary heart disease (CHD) or CHD risk equivalents is less than 100 mg/dL, with an optional target of less than 70 mg/dL. More recent data suggest, however, that the physiologically ...

Triglycerides (TG), the so-called forgotten lipid, are so very important to both human life and unfortunately to atherogenesis. Of course the correct term is triacylglycerol. Three acyl groups (fatty acids) are attached to a glycerol molecule. Triglycerides are an archaic term, which we all keep using. Serum TG refers to all of the TG trafficked within all of the lipoproteins that exist in a de...

Background: The evaluation of metabolic syndrome in a society predisposed to the diabetes mellitus epidemic opens a new avenue to understanding this rapidly growing global metabolic problem. Although Saudi Arabia reports one of the highest prevalence levels of obesity and diabetes, a very limited number of epidemiological studies have examined the prevalence of metabolic syndrome. Therefore, th...

OBJECTIVE We aimed to evaluate the prevalence of hypertriglyceridemic waist (HTGW) phenotype among users of primary health care using two different cutoff points used in the literature. METHODS We evaluated adults and elderly individuals of both sexes who attended the same level of primary health care. HTGW phenotype was determined with measurements of waist circumference (WC) and triglycerid...

The metabolic syndrome (MS) is a common phenotype associated with an increased risk for type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD). Although there is no universally accepted definition for the MS, affected individuals commonly have a cluster of features, including abdominal obesity, hypertension, dyslipidaemia and dysglycaemia. The first formal definition of the MS was pro...

The intent of this review is to update the science of emerging cardiometabolic risk factors that were listed in the National Cholesterol Education Program (NCEP) Adult Treatment Panel-III (ATP-III) report of 2001 (updated in 2004). At the time these guidelines were published, the evidence was felt to be insufficient to recommend these risk factors for routine screening of cardiovascular disease...

Objective: It has been established that metabolic syndrome is prevalent in patients with systemic lupus erythematosus (SLE). The objective of this study was to investigate the effect at baseline on new-onset cardiovascular disease (CVD) SLE. Methods: demographic and lupus-related clinical variables 229 SLE were collected from Korean Lupus Network (KORNET) registry. Metabolic defined by modified...